MedTrace Logo

Using EEG to Predict Depression Treatment Response to rTMS in Patients With Major Depression

NCT04575285 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2024-06-25

No results posted yet for this study

Summary

Repetitive Transcranial Magnetic Stimulation (rTMS) is a promising, novel, non-invasive therapy for depression. The study is looking at changes in specific electroencephalogram parameters in depressed patients treated with rTMS can serve as predictors of depression treatment response among cancer patents undergoing rTMS treatment of depression.

Conditions

Interventions

DIAGNOSTIC_TEST

Electroencephalogram (EEG)

EEG measures brain activity by recording the spontaneous brain electrical activity and evoked responses non-invasively from the scalp. Reusable Tangle Free 10mm EEG Cup Electrodes will be placed on the subject's scalp using the 10-20 system montage.

Sponsors & Collaborators

  • Florida International University

    collaborator OTHER

  • Baptist Health South Florida

    lead OTHER

Principal Investigators

  • Geetha Nampiaparampil, MD · Miami Cancer Institute (MCI) at Baptist Health, Inc.

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-30
Primary Completion
2030-12-01
Completion
2031-12-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04575285 on ClinicalTrials.gov